Opendata, web and dolomites

HEDIMED SIGNED

Human Exposomic Determinants of Immune Mediated Diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HEDIMED project word cloud

Explore the words cloud of the HEDIMED project. It provides you a very rough idea of what is the project "HEDIMED" about.

countries    supplementary    forums    asthma    tools    start    combination    technologies    join    bhc    innovations    associations    clinical    preventive    industrial    celiac    determinants    heap    epidemic    economical    exposomic    interactions    diabetes    constituting    women    pregnant    disease    followed    exploratory    athlete    driving    efforts    causal    altogether    prospectively    cohorts    therapeutic    offers    exposome    models    societal    treatments    sc1    2018    diseases    play    academic    biological    birth    life    eximious    2020    trials    28    hedimed    underlying    human    350    interventions    cutting    cross    resource    economic    toolbox    multidisciplinary    chronic    rapid    fetal    omics    forces    organ    exploited    imds    exposomice    stakeholders    datamining    genetic    ephor    combined    sectional    expanse    children    immune    remedia    health    synergy    longitools    generate    identification    600    samples    functional    medical    data    cell    childhood    emphasis    ways    edge    mediated    multiplex    allergies    inclusion    equal    burden    latest    huge    imd    culture    paid    diagnostic   

Project "HEDIMED" data sheet

The following table provides information about the project.

Coordinator
TAMPEREEN KORKEAKOULUSAATIO SR 

Organization address
address: KALEVANTIE 4
city: TAMPERE
postcode: 33100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Total cost 11˙992˙338 €
 EC max contribution 11˙992˙338 € (100%)
 Programme 1. H2020-EU.3.1.2. (Preventing disease)
 Code Call H2020-SC1-2019-Single-Stage-RTD
 Funding Scheme RIA
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2024-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TAMPEREEN KORKEAKOULUSAATIO SR FI (TAMPERE) coordinator 1˙562˙782.00
2    TURUN YLIOPISTO FI (Turku) participant 1˙160˙371.00
3    Teknologian tutkimuskeskus VTT Oy FI (Espoo) participant 954˙253.00
4    UNIVERZITA KARLOVA CZ (PRAHA 1) participant 816˙037.00
5    LUNDS UNIVERSITET SE (LUND) participant 646˙512.00
6    FOLKEHELSEINSTITUTTET NO (OSLO) participant 644˙373.00
7    BAYLOR COLLEGE OF MEDICINE US (HOUSTON TX) participant 596˙872.00
8    TERVEYDEN JA HYVINVOINNIN LAITOS FI (HELSINKI) participant 586˙925.00
9    HELSINGIN YLIOPISTO FI (HELSINGIN YLIOPISTO) participant 522˙242.00
10    TECHNISCHE UNIVERSITAET GRAZ AT (GRAZ) participant 470˙233.00
11    SIHTASUTUS TARTU ULIKOOLI KLIINIKUM EE (TARTU) participant 467˙550.00
12    UNIVERSITA DEGLI STUDI DI SIENA IT (SIENA) participant 457˙602.00
13    TARTU ULIKOOL EE (TARTU) participant 417˙811.00
14    PIRKANMAA HOSPITAL DISTRICT FI (TAMPERE) participant 414˙205.00
15    DEN SELVEJENDE INSTITUTION DANSK BORNEASTMA CENTER DK (GENTOFTE) participant 397˙915.00
16    CSEM CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA - RECHERCHE ET DEVELOPPEMENT CH (NEUCHATEL) participant 355˙930.00
17    CESKA ZEMEDELSKA UNIVERZITA V PRAZE CZ (PRAHA) participant 298˙436.00
18    OULUN YLIOPISTO FI (OULU) participant 287˙096.00
19    GNOMON Informatics SA EL (Thessaloniki) participant 279˙858.00
20    EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH DE (BONN) participant 249˙572.00
21    SATELLIO OY FI (HELSINKI) participant 219˙351.00
22    LUONNONVARAKESKUS FI (HELSINKI) participant 186˙405.00

Map

 Project objective

Immune-mediated diseases (IMDs) are increasing rapidly in the developed countries constituting a huge medical, economic and societal challenge. The reasons to this epidemic are not known, but exposome needs to play an important role since genetic factors cannot explain such a rapid change. In the HEDIMED project altogether 20 academic and industrial partners will join their multidisciplinary and supplementary forces to identify exposomic determinants which are driving this epidemic. The project is based on a combination of data and biological samples from large clinical cohorts constituting the largest clinical resource in this field including 350.000 pregnant women, 28.000 children prospectively followed from birth and 6.600 children from cross-sectional studies. HEDIMED focuses on common chronic IMDs that cause a significant disease burden, including type 1 diabetes, celiac disease, allergies and asthma. Exposomic disease determinants and the underlying biological pathways will be identified by exploratory approach using advanced omics and multiplex technologies combined with cutting–edge datamining technologies. Particular emphasis is paid on early fetal and childhood exposome since the disease process is known to start early. Inclusion of several IMDs makes it possible to identify determinants that are common for many IMDs facilitating the development of widely operating treatments. HEDIMED includes also data and samples from clinical trials that have used exposomice interventions and cell and organ culture models to help the identification of causal associations. HEDIMED will generate an open-access toolbox that offers various kind of data, new technologies, interactions forums, latest information and functional tools for several stakeholders to facilitate the efforts to find ways to control the IMD epidemic. HEDIMED will generate several innovations which can become exploited widely in diagnostic, therapeutic, preventive and health-economical applications. HEDIMED will work together with the other projects (EXPANSE, HEAP, ATHLETE, EQUAL-LIFE, LONGITOOLS, EPHOR, REMEDIA and EXIMIOUS) funded within the Human Exposome programme call H2020 SC1-BHC-2018-2020, in order to achieve collaboration and synergy

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HEDIMED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HEDIMED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.2.)

HEAP (2020)

Human Exposome Assessment Platform

Read More  

ECRC (2019)

Developing a diverse portfolio of vaccine candidates for Rift Valley Fever, Chikungunya and Ebola

Read More  

EXIMIOUS (2020)

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome

Read More